Wharton Business Group, LLC Amgen Inc Transaction History

Wharton Business Group, LLC

$2.23 Billion
Q3 2024

A detailed history of Wharton Business Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Wharton Business Group, LLC holds 1,176 shares of AMGN stock, worth $329,291. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,176

Previous 1,176 -0.0%

Holding current value

$329,291

Previous $367,000 3.27%

% of portfolio

0.02%

Previous 0.02%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$262.75 - $319.31 $13,663 - $16,604	52 Added 4.63%	1,176 $367,000
Q2 2023 Aug 07, 2023	BUY	$214.27 - $253.37 $214 - $253	1 Added 0.09%	1,124 $250,000
Q1 2023 May 04, 2023	SELL	$225.79 - $275.2 $225 - $275	-1 Reduced 0.09%	1,123 $271,000
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $46,722 - $59,366	-204 Reduced 15.36%	1,124 $295,000
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $264,112 - $302,252	1,328 New	1,328 $299,000
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $278,498 - $326,294	-1,312 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$233.58 - $259.14 $46,716 - $51,828	-200 Reduced 13.23%	1,312 $320,000
Q1 2021 May 10, 2021	BUY	$221.91 - $258.6 $6,435 - $7,499	29 Added 1.96%	1,512 $376,000
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $19,781 - $24,274	100 Added 7.23%	1,483 $350,000
Q1 2020 Apr 27, 2020	BUY	$182.24 - $241.7 $36,448 - $48,340	200 Added 16.91%	1,383 $280,000
Q4 2019 Feb 04, 2020	BUY	$189.21 - $243.2 $223,835 - $287,705	1,183 New	1,183 $285,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wharton Business Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wharton Business Group, LLC with notifications on news.

Account

Wharton Business Group, LLC Amgen Inc Transaction History